IFI-M · HPB Tri-Axis Dominant-Primary Series

Specimen SS-F-M3-00233 // MULTI-AXIS · IFI-M

HPB Tri-Axis Dominant-Primary Series II-PR

Capsicum chinense

Habanero

Tier IIHPB Tri-Axis Dominant-Primary Series

Target Trait

1.52×

fold-change

Heat-dominant tri-axis P+B modulated fold-change

Technical Specifications

SKU

SS-F-M3-00233

Genomic Edits

8

GC Content

47.5%

Construct Length

4,841 bp

Promoter System

Ubiquitin / T7

Expression System

Protoplast PEG-fusion

Host Strain

PEG-mediated

Receptor Target

TRPV1 + TRPA1 + TAS2R38 (suppression)

IFI Score

152

Pathway Edits

  • TRPV1 pathway primary gene cluster for heat (IFI-H) tri-axis component
  • TRPA1 pathway primary gene cluster for sharp (IFI-P) tri-axis component
  • TAS2R38 (suppression) pathway primary gene cluster for bitter-attenuation (IFI-B) tri-axis component
  • Tri-axis metabolic flux partitioning hub for concurrent HPB pathway operation
  • Cross-pathway regulatory circuit for heat-dominant HPB triple-axis expression
  • Cofactor regeneration system (NADPH, ATP, acetyl-CoA) supporting triple-axis concurrent production

Key Interventions

Triple-axis receptor co-activation: TRPV1, TRPA1, and TAS2R38 (suppression) pathways simultaneously engineeredHeat-dominant tri-axis expression strategy (HPB) with cross-pathway flux managementPEG-mediated co-transfection of axis constructs for rapid phenotypic screening of multi-axis combinations

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier II HPB triple-axis construct for advanced multi-modal sensory architecture combining heat, sharp, and bitter-attenuation axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$699 · Tier II License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?